- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03289663
Effectiveness Study of New Generation Bednets in the Context of Conventional Insecticide Resistance in the Democratic Republic of the Congo (Net-PBO)
Effectiveness Study of Bednets Treated With Synegistic Combination of Insectcides in an Area With Pyrethroid-resistant Vectors in the Democratic Republic of the Congo
Despite the mass distribution of LLINs (long-lasting insecticidal nets) as a Malaria control strategy, populations are still continuously exposed to a high frequency of malarial inoculation in some countries. The situation can be explained by a swift increase in the resistance of Anopheles to common insecticides. To preserve the gains of insecticides and improve their effectiveness, a new generation of bednets treated with piperonyl butoxide combination insectides have emerged.But more evidence is needed to plead for scale up of their usage. The lack of information relating to the additional impact of that combination on the transmission of Malaria, its relative efficacy in real-life setting and its safety in users are the rationale for more investigation.This will be a randomized controlled study on a dynamic cohort of households with 1680, 0-10 years-old subjects in 30 villages will be recruited to compute the effectiveness of this new tool.
The findings will be useful information for decision-making by national malaria control programs, their partners, the international community and the bednet manufacturers with regard to the effectiveness of the new combination of insecticides in real-life context. The results will also enable a better design of the tool in the future and a broader understanding of long-term dynamics for sustainability, as well as identification of some factors with negative impacts on the benefits of the strategy.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Kongo-Central
-
Kisantu, Kongo-Central, Congo, The Democratic Republic of the
- Hôpital Général de Référence Saint Luc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria : -households where there are one or more children below the age of 10 years;
- Ability and willingness of the head of the household to participate based on signed informed consent (or fingerprint) and with the assistance of an impartial witness (if the head of the household is illiterate)
Exclusion Criteria :
- refusal of the head of household to participate
- known allergy to insecticides
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Control
The arm will receive bednets treated with conventional insecticide (Pyrethroid)
|
Conventional insecticide
|
Experimental: Experimental
The arm will receive bednets treated with new generation of insecticides (synergistic combination of insecticides)
|
third generation insecticide -treated bednets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence rate of laboratory confirmed clinical cases of Malaria
Time Frame: Participants will be actively followed up for 12 months. And any suspected case of clinical Malaria will immediately lead to microscopy and RDT for confirmation
|
Microscopy to confirm the diagnosis of Malaria
|
Participants will be actively followed up for 12 months. And any suspected case of clinical Malaria will immediately lead to microscopy and RDT for confirmation
|
Sporozoite rate
Time Frame: Anopheles mosquitoes will be captured every 3 months during 1 year
|
Sporozoite detection by ELISA to determine infectivity of anopheles
|
Anopheles mosquitoes will be captured every 3 months during 1 year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NET-06-08-76
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insecticide Resistance
-
University of EdinburghToxicology Society of BangladeshRecruitingPesticide Poisoning | Anticholinesterase Insecticide PoisoningBangladesh
-
Michigan State UniversityBoston University; National Institute of Allergy and Infectious Diseases (NIAID) and other collaboratorsRecruitingMalaria, Malaria Vaccine, Insecticide-treated BednetsMalawi
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingIncreased Drug Resistance | Resistance Bacterial | Drug Resistance, MicrobialBangladesh
-
Methodist University, North CarolinaUnknownResistance Training With Traditional Periodization Model | Resistance Training With Conjugate Training ModelUnited States
-
Human Biome Institute S.A.RecruitingAntimicrobial Drug Resistance | Drug Resistance, BacterialPoland
-
University of JyvaskylaRecruiting
-
Chinese University of Hong KongCompletedAntimicrobial ResistanceHong Kong
-
University of Central FloridaCompletedResistance TrainingUnited States
-
ART Fertility Clinics LLCMerck Serono International SACompletedProgesterone ResistanceUnited Arab Emirates